The international collaborative study of maternal phenylketonuria: Status report 1994

R. Koch, H. L. Levy, Reuben Matalon, B. Rouse, W. B. Hanley, F. Trefz, C. Azen, E. G. Friedman

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Neonatal screening for phenylketonuria (PKU) has created a problem as females with PKU are reaching child-bearing age. Surveys have revealed that maternal phenylalanine blood concentrations greater than 1200 μmol/l are associated with fetal microcephaly, congenital heart defects and intrauterine growth retardation. It is estimated that as many as 3000 hyperphenylalaninemic females may be at risk of producing these fetal abnormalities. To examine this problem, the international maternal PKU collaborative study was developed to evaluate the efficacy of a phenylalanine-restricted diet in reducing fetal morbidity. Preliminary findings have indicated that phenylalanine restriction should begin before conception for females with PKU planning a pregnancy. Dietary control should maintain maternal blood phenylalanine levels between 120 and 360 μmol/l and should provide adequate energy, protein, vitamin and mineral intake. Pregnant hyperphenylalaninemic females who achieved metabolic control after conception or by the 10th week of pregnancy had a better offspring outcome than anticipated. The results of 402 pregnancies are reviewed.

Original languageEnglish (US)
Pages (from-to)111-119
Number of pages9
JournalActa Paediatrica, International Journal of Paediatrics, Supplement
Volume83
Issue number407
StatePublished - 1994
Externally publishedYes

Fingerprint

Maternal Phenylketonuria
Phenylalanine
Phenylketonurias
Pregnancy
Mothers
Reducing Diet
Neonatal Screening
Microcephaly
Fetal Growth Retardation
Congenital Heart Defects
Vitamins
Minerals
Morbidity
Proteins

Keywords

  • Congenital heart disease
  • Fetal abnormalities
  • Microcephaly
  • Phenylketonuria
  • Pregnancy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Koch, R., Levy, H. L., Matalon, R., Rouse, B., Hanley, W. B., Trefz, F., ... Friedman, E. G. (1994). The international collaborative study of maternal phenylketonuria: Status report 1994. Acta Paediatrica, International Journal of Paediatrics, Supplement, 83(407), 111-119.

The international collaborative study of maternal phenylketonuria : Status report 1994. / Koch, R.; Levy, H. L.; Matalon, Reuben; Rouse, B.; Hanley, W. B.; Trefz, F.; Azen, C.; Friedman, E. G.

In: Acta Paediatrica, International Journal of Paediatrics, Supplement, Vol. 83, No. 407, 1994, p. 111-119.

Research output: Contribution to journalArticle

Koch, R, Levy, HL, Matalon, R, Rouse, B, Hanley, WB, Trefz, F, Azen, C & Friedman, EG 1994, 'The international collaborative study of maternal phenylketonuria: Status report 1994', Acta Paediatrica, International Journal of Paediatrics, Supplement, vol. 83, no. 407, pp. 111-119.
Koch, R. ; Levy, H. L. ; Matalon, Reuben ; Rouse, B. ; Hanley, W. B. ; Trefz, F. ; Azen, C. ; Friedman, E. G. / The international collaborative study of maternal phenylketonuria : Status report 1994. In: Acta Paediatrica, International Journal of Paediatrics, Supplement. 1994 ; Vol. 83, No. 407. pp. 111-119.
@article{096d3918fbfc445e9e90e4c2110a7f0e,
title = "The international collaborative study of maternal phenylketonuria: Status report 1994",
abstract = "Neonatal screening for phenylketonuria (PKU) has created a problem as females with PKU are reaching child-bearing age. Surveys have revealed that maternal phenylalanine blood concentrations greater than 1200 μmol/l are associated with fetal microcephaly, congenital heart defects and intrauterine growth retardation. It is estimated that as many as 3000 hyperphenylalaninemic females may be at risk of producing these fetal abnormalities. To examine this problem, the international maternal PKU collaborative study was developed to evaluate the efficacy of a phenylalanine-restricted diet in reducing fetal morbidity. Preliminary findings have indicated that phenylalanine restriction should begin before conception for females with PKU planning a pregnancy. Dietary control should maintain maternal blood phenylalanine levels between 120 and 360 μmol/l and should provide adequate energy, protein, vitamin and mineral intake. Pregnant hyperphenylalaninemic females who achieved metabolic control after conception or by the 10th week of pregnancy had a better offspring outcome than anticipated. The results of 402 pregnancies are reviewed.",
keywords = "Congenital heart disease, Fetal abnormalities, Microcephaly, Phenylketonuria, Pregnancy",
author = "R. Koch and Levy, {H. L.} and Reuben Matalon and B. Rouse and Hanley, {W. B.} and F. Trefz and C. Azen and Friedman, {E. G.}",
year = "1994",
language = "English (US)",
volume = "83",
pages = "111--119",
journal = "Acta Paediatrica, International Journal of Paediatrics, Supplement",
issn = "0803-5326",
publisher = "Taylor and Francis Ltd.",
number = "407",

}

TY - JOUR

T1 - The international collaborative study of maternal phenylketonuria

T2 - Status report 1994

AU - Koch, R.

AU - Levy, H. L.

AU - Matalon, Reuben

AU - Rouse, B.

AU - Hanley, W. B.

AU - Trefz, F.

AU - Azen, C.

AU - Friedman, E. G.

PY - 1994

Y1 - 1994

N2 - Neonatal screening for phenylketonuria (PKU) has created a problem as females with PKU are reaching child-bearing age. Surveys have revealed that maternal phenylalanine blood concentrations greater than 1200 μmol/l are associated with fetal microcephaly, congenital heart defects and intrauterine growth retardation. It is estimated that as many as 3000 hyperphenylalaninemic females may be at risk of producing these fetal abnormalities. To examine this problem, the international maternal PKU collaborative study was developed to evaluate the efficacy of a phenylalanine-restricted diet in reducing fetal morbidity. Preliminary findings have indicated that phenylalanine restriction should begin before conception for females with PKU planning a pregnancy. Dietary control should maintain maternal blood phenylalanine levels between 120 and 360 μmol/l and should provide adequate energy, protein, vitamin and mineral intake. Pregnant hyperphenylalaninemic females who achieved metabolic control after conception or by the 10th week of pregnancy had a better offspring outcome than anticipated. The results of 402 pregnancies are reviewed.

AB - Neonatal screening for phenylketonuria (PKU) has created a problem as females with PKU are reaching child-bearing age. Surveys have revealed that maternal phenylalanine blood concentrations greater than 1200 μmol/l are associated with fetal microcephaly, congenital heart defects and intrauterine growth retardation. It is estimated that as many as 3000 hyperphenylalaninemic females may be at risk of producing these fetal abnormalities. To examine this problem, the international maternal PKU collaborative study was developed to evaluate the efficacy of a phenylalanine-restricted diet in reducing fetal morbidity. Preliminary findings have indicated that phenylalanine restriction should begin before conception for females with PKU planning a pregnancy. Dietary control should maintain maternal blood phenylalanine levels between 120 and 360 μmol/l and should provide adequate energy, protein, vitamin and mineral intake. Pregnant hyperphenylalaninemic females who achieved metabolic control after conception or by the 10th week of pregnancy had a better offspring outcome than anticipated. The results of 402 pregnancies are reviewed.

KW - Congenital heart disease

KW - Fetal abnormalities

KW - Microcephaly

KW - Phenylketonuria

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=0028656487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028656487&partnerID=8YFLogxK

M3 - Article

VL - 83

SP - 111

EP - 119

JO - Acta Paediatrica, International Journal of Paediatrics, Supplement

JF - Acta Paediatrica, International Journal of Paediatrics, Supplement

SN - 0803-5326

IS - 407

ER -